Overview

A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting

Status:
Not yet recruiting

Trial end date:
2025-01-29

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the effect of deucravacitinib on quality of life (QoL) in participants with plaque psoriasis in a community setting.

Phase:

Phase 4

Details

Lead Sponsor:

Bristol-Myers Squibb

Treatments:

BMS-986165